EDITORIAL article
Front. Public Health
Sec. Infectious Diseases: Epidemiology and Prevention
This article is part of the Research TopicWorld Hepatitis Day 2024: Advancing Hepatitis Elimination, Public Health Strategies and InnovationsView all 22 articles
Editorial: World Hepatitis Day 2024: Advancing Hepatitis Elimination, Public Health Strategies, and Innovations
Provisionally accepted
Arturo Panduro1,2*
Sonia Roman1,2- 1Department of Genomic Medicine in Hepatology, CIvil Hospital of Guadalajara, Fray Antonio Alcalde, Guadalajara, Jalisco, Mexico
- 2Health Sciences Center, University of Guadalajara, Guadalajara, Jalisco, Mexico
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Viral hepatitis remains a major global health challenge, causing over one million deaths each year.Although hepatitis B vaccination and curative treatments for hepatitis C have improved outcomes, efforts to eliminate the disease remain inconsistent across regions. The World Health Organization (WHO) has set a goal to eliminate viral hepatitis as a public health threat by 2030 [1]. However, the path to this goal is complicated by new and overlapping causes of liver injury, such as metabolic dysfunction-associated steatotic liver disease (MASLD) [2] and sepsis-related liver injury (SRLI) [3], which can accelerate disease progression and make diagnosis more difficult. These overlapping causes emphasize the importance of integrated liver health strategies that combine prevention, awareness, metabolic risk reduction, and better diagnostics to achieve elimination targets.This Topic Research World Hepatitis Day 2024 provides a timely opportunity to assess global efforts, identify ongoing gaps, and build momentum toward the WHO's target. Sadly, the burden of hepatitis disproportionately affects low-and middle-income countries, where limited resources, weaker health systems, and socioeconomic inequalities restrict access to prevention, screening, and treatment. Stigma, migration patterns, and social determinants of health further complicate epidemiological trends and hinder engagement with care. This collection includes original articles, meta-analyses, study protocols, and viewpoints from various regions and disciplines, all focused on a central theme: the urgent need to translate epidemiological findings, preventive strategies, and innovative tools into tangible progress toward the eradication of hepatitis. We invite our readers to explore this compilation, which covers epidemiology, awareness, immune/vaccination response, innovation, and regional experiences, all aligned with the WHO's elimination goals. Despite progress worldwide, the fight against hepatitis faces ongoing, region-specific challenges.In China, hepatitis elimination strategies are fragmented and unfocused, increasing the risk of non-
Keywords: Antiviral Agents, Blood Safety, Disease elimination, Epidemiology, health equity, Public Health, Vaccination, Viral Hepatitis
Received: 11 Dec 2025; Accepted: 11 Dec 2025.
Copyright: © 2025 Panduro and Roman. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Arturo Panduro
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.